| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 1,493 | 227 | 137 | 448 |
| Depreciation and amortization | 372 | 251 | 129 | 405 |
| Pension and postretirement benefit expense | 49 | 32 | 15 | 30 |
| Stock-based compensation expense | 124 | 83 | 49 | 87 |
| Gain on sale of business | 1,518 | - | - | 0 |
| Purification and filtration transaction costs | -86 | - | - | - |
| Deferred income taxes | -47 | -177 | -144 | -93 |
| Accounts receivable | -36 | 15 | -6 | -14 |
| Due from related parties | -37 | -4 | -5 | -200 |
| Inventories | 134 | 77 | 32 | 99 |
| Accounts payable | 74 | 23 | 9 | 200 |
| Due to related parties | 18 | -6 | -6 | -393 |
| Accrued compensation | -9 | -47 | -95 | - |
| All other operating activities net | -135 | -100 | -44 | 167 |
| Net cash provided by operating activities | 274 | 198 | 29 | 966 |
| Purchases of property, plant and equipment | 316 | 219 | 109 | 253 |
| Proceeds from sale of business | 3,870 | - | - | 0 |
| Other net | 12 | 5 | 5 | - |
| Net cash provided by (used in) investing activities | 3,542 | -224 | -114 | -253 |
| Repayment of debt | 2,970 | 200 | 100 | 200 |
| Net transfers to 3m | 21 | 30 | 31 | 8,247 |
| Proceeds from long-term debt, net of issuance costs | 0 | 0 | 0 | 8,303 |
| Other net | 49 | -19 | -8 | 8 |
| Net cash used in financing activities | -2,942 | -249 | -139 | -136 |
| Effect of exchange rate changes on cash and cash equivalents | 6 | 7 | 1 | 1 |
| Net increase (decrease) in cash and cash equivalents | 880 | -268 | -223 | 578 |
| Cash and cash equivalents at beginning of period | 762 | - | - | 194 |
| Cash and cash equivalents at end of period | 1,642 | - | - | 772 |
Solventum Corp (SOLV)
Solventum Corp (SOLV)